Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung Cancer

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatments over the last 10 years, with even increasing indications in many neoplasms. Non-small cell lung cancer (NSCLC) is considered highly immunogenic, and ICIs have found a wide set of applications in this area, in both early and ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Gemelli, Maria, Noonan, Douglas M., Carlini, Valentina, Pelosi, Giuseppe, Barberis, Massimo, Ricotta, Riccardo, Albini, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194506/
https://www.ncbi.nlm.nih.gov/pubmed/35712510
http://dx.doi.org/10.3389/fonc.2022.886440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194506/
https://www.ncbi.nlm.nih.gov/pubmed/35712510
http://dx.doi.org/10.3389/fonc.2022.886440

Ejemplares similares